(Q33883094)

29 July 2017

1 reference

title

Beta-adrenergic receptor-G protein-adenylyl cyclase signal transduction in the failing heart (English)

1 reference

29 July 2017

Vatner DE

1

1 reference

29 July 2017

Asai K

2

1 reference

29 July 2017

Iwase M

3

1 reference

29 July 2017

Ishikawa Y

4

1 reference

29 July 2017

Shannon RP

5

1 reference

29 July 2017

Homcy CJ

6

1 reference

29 July 2017

Vatner SF

7

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 June 1999

1 reference

American Journal of Cardiology

29 July 2017

published in

1 reference

29 July 2017

volume

83

1 reference

29 July 2017

issue

12A

1 reference

29 July 2017

page(s)

80H-85H

1 reference

Rapid beta-adrenergic modulation of cardiac calcium channel currents by a fast G protein pathway

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900266-0

Plasma norepinephrine in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900266-0

Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900266-0

CATECHOLAMINE EXCRETION AND CARDIAC STORES OF NOREPINEPHRINE IN CONGESTIVE HEART FAILURE

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900266-0

Mechanism of norepinephrine depletion in experimental heart failure produced by aortic constriction in the guinea pig

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900266-0

Effects of cardiac denervation on development of heart failure and catecholamine desensitization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900266-0

Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900266-0

Myocardial beta-adrenergic receptor function during the development of pacing-induced heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900266-0

Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900266-0

Increase of Gi alpha in human hearts with dilated but not ischemic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900266-0

Increased messenger RNA level of the inhibitory G protein alpha subunit Gi alpha-2 in human end-stage heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900266-0

Downregulation of adenylylcyclase types V and VI mRNA levels in pacing-induced heart failure in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900266-0

Regulation of adenylyl cyclase-coupled beta-adrenergic receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900266-0

Depressed heart rate variability and arterial baroreflex in conscious transgenic mice with overexpression of cardiac Gsalpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900266-0

Adverse effects of chronic endogenous sympathetic drive induced by cardiac GS alpha overexpression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900266-0

Apoptosis of cardiac myocytes in Gsalpha transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900266-0

Overexpression of myocardial Gsalpha prevents full expression of catecholamine desensitization despite increased beta-adrenergic receptor kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900266-0

Cardiac Gsalpha overexpression enhances L-type calcium channels through an adenylyl cyclase independent pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900266-0

Differential regulation of inotropy and lusitropy in overexpressed Gsalpha myocytes through cAMP and Ca2+ channel pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900266-0

"Stress-responsive" mitogen-activated protein kinases (c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900266-0

Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900266-0

Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900266-0

Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900266-0

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900266-0

Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900266-0

Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900266-0

Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900266-0

Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900266-0

10.1016/S0002-9149(99)00266-0

7 January 2021

Identifiers

DOI

1 reference

29 July 2017

1 reference